Rebecca Hollins

Associate Director, Clinical Development Compliance at Agios Pharmaceuticals

Rebecca Hollins has over 19 years of work experience in the pharmaceutical industry. Rebecca started their career in 2003 at The Medicines Company, where they served as an Executive Assistant to the CEO before transitioning to the role of Manager of Corporate Communications and Investor Relations. In 2009, they were promoted to Senior Manager in the same department. From 2012 to 2015, they worked as a Senior Compliance Project Manager in Global Contracting and Business Ethics at The Medicines Company. In 2016, they joined PRA Health Sciences as a Project Manager for Medical Compliance Training and Medical Affairs. In 2018, they moved to Bristol-Myers Squibb, where they served as an Associate Director for Customer and Market Insights, focusing on Compliance and Operational Excellence. Presently, they are an Associate Director of Clinical Development Compliance at Agios Pharmaceuticals since 2022. Throughout their career, Rebecca has demonstrated expertise in compliance, project management, and corporate communications.

Rebecca Hollins has a diverse education history. In 2010, they attended Centenary College and graduated in 2014 with a Bachelor's Degree in Business Administration. During their time at Centenary College, they focused on studying business-related subjects.

Rebecca also pursued a certification program in the health care compliance field. From an unspecified start date, they attended the Seton Hall University School of Law and completed the Health Care Compliance Certification Program in 2013. The specific field of study for this program is not provided.

Later, Rebecca furthered their education by obtaining the Project Management Professional (PMP) certification from the Project Management Institute. Rebecca completed this certification in 2019, demonstrating their expertise in project management.

In addition to their formal education, Rebecca has obtained various certifications to enhance their knowledge and skills. In August 2022, they achieved the Risk-Based Quality Management certification from Cyntegrity | Data Science for Clinical Trials. Furthermore, in April 2023, Rebecca acquired the MyRBQM Essentials BB Mastery certification, also from Cyntegrity | Data Science for Clinical Trials.

Overall, Rebecca Hollins has a strong educational background, including a bachelor's degree in business administration, a health care compliance certification, and the esteemed Project Management Professional (PMP) certification. Rebecca has also pursued additional certifications to further develop their expertise in the fields of quality management and data science for clinical trials.

Links

Previous companies

Bristol-Myers Squibb logo